Company intelligence

BMRA

Biomerica, Inc. · NASDAQ · Healthcare

Price$2.14-4.17% · −$0.09

Market cap6.62MEquity value

P / E-1.7Trailing ratio

Volume8.4KLatest session

Market data

BMRA price chart

TradingView

Related signals

1 min delayed

Browse public BMRA signals with their source context and measured market impact. Open any signal for its permanent analysis page.

BMRAJan 16, 2025-10.25% since signal

Biomerica Stock Trades 200% Higher After Prostate Screening Test Receives Approval

BMRA's stock surged with 139.2 million in session volume. Fortel PSA Screening Test received UAE's health ministry approval. Test accuracy is 100% sensitivity and 97.5% accuracy. Prostate cancer represents a significant global health issue. Company saw a 5% increase in net sales year-over-year.

View signal analysis

Research